Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03459469
Title Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Iterion Therapeutics

desmoid tumor



Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43202 United States Details
MD Anderson Cancer Center Houston Texas 770030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Princess Margaret Cancer Center Toronto Ontario Canada Details
*Shaded cells indicate that there was no data available from for the field